Amanta Healthcare Launches INR 126 Cr IPO

The IPO is slated for listing on both BSE and NSE, with a tentative listing date of September 4, 2025.

Amanta Healthcare Limited has launched its initial public offering (IPO) worth ₹126 crore, entirely comprising a fresh issue of 1 crore equity shares.

The price band has been set between ₹120 and ₹126 per share. The lot size for retail investors is 119 shares, requiring a minimum investment of ₹14,994 at the upper price. For small non-institutional investors, the minimum application is 14 lots (1,666 shares) at ₹209,916, while for large non-institutional investors it is 67 lots (7,973 shares) at ₹1,004,598.

The IPO is slated for listing on both BSE and NSE, with a tentative listing date of September 4, 2025. Beeline Capital Advisors Pvt. Ltd. is the book-running lead manager, and MUFG Intime India Pvt. Ltd. is the registrar.

Amanta Healthcare, founded in December 1994, develops and markets sterile liquid pharmaceutical products, with a focus on parenteral solutions packaged using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company also manufactures medical devices.

Proceeds from the IPO will be used to fund civil construction and equipment purchases for new manufacturing lines at SteriPort and SVP in Hariyala, Kheda, Gujarat, in addition to general corporate purposes.

Between March 31, 2024, and March 31, 2025, the company’s sales declined by 2 percent, but its profit after tax rose by 189 percent.

Highlighting potential risks, Amanta Healthcare noted that all its manufacturing operations are concentrated at a single facility in Hariyala, Kheda, Gujarat. “Any delay in production at, or shutdown of, our manufacturing facility may in turn adversely affect our business, financial condition and results of operations,” the company stated.

Stay tuned for more such updates on Digital Health News